Access cutting-edge hiv treatment through this clinical trial at a research site in Cincinnati. Study-provided care at no cost to qualified participants.
Access hiv specialists in Cincinnati at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hiv treatment provided free
The purpose of this study is to evaluate the safety, tolerability, and efficacy of therapeutic vaccination with chimpanzee adenovirus ChAdOx1- and poxvirus modified vaccinia Ankara (MVA)-vectored conserved mosaic T-cell vaccines in a sequential regimen with the toll-like receptor 7 (TLR7) agonist vesatolimod (VES) and two broadly neutralizing antibodies (bNAbs) compared to placebo, to induce HIV-1 control during analytic treatment interruption (ATI).
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Check if you qualify for this hiv clinical trial in Cincinnati, OH
If you're searching for hiv treatment options in Cincinnati, OH, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Cincinnati research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hiv specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.